BridgeMD
New treatment option for Pancreatic Cyst
Official title Study Using Hyperpolarized 13C-Pyruvate Magnetic Resonance Spectroscopic Imaging in Patients With Pancreatic Cysts Undergoing Surgical Resection
ClinicalTrials.gov ID: NCT05873699
What this study is testing
What is Hyperpolarized 13-C-pyruvate?
Hyperpolarized 13-C-pyruvate is an investigational medicine, given as an injectable medicine, being studied as a potential treatment for pancreatic cyst.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- To learn if Hyperpolarized C-Pyruvate Magnetic Resonance (HP-MR) Spectroscopic Imaging can help doctors detect low-risk (benign) and high-risk (malignant) cysts.
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients ≥ 18 years old. Patients under 18 are excluded due to their potential inability to understand and consent independently to the methods...
- Patients with pancreatic cyst/s
- Patients who will undergo surgical resection (or cyst wall biopsy) of pancreatic cysts
- Patients able to understand and willing to sign a written informed consent document
- Both English-speaking and non-English-speaking patients are eligible for participation
You likely can't join if
- Contraindication to MRI
- Electrically, magnetically, or mechanically activated implants that would preclude MRI
- Allergy to Gadavist IV contrast
- History of cardiac arrhythmias
- Pregnancy or breastfeeding women
- Women of child-bearing age that are sexually active and not using birth control
See the full eligibility criteria
- Patients ≥ 18 years old. Patients under 18 are excluded due to their potential inability to understand and consent independently to the methods required for the study drug use and its potential risks and benefits.
- Patients with pancreatic cyst/s
- Patients who will undergo surgical resection (or cyst wall biopsy) of pancreatic cysts
- Patients able to understand and willing to sign a written informed consent document
- Both English-speaking and non-English-speaking patients are eligible for participation
- Contraindication to MRI
- Electrically, magnetically, or mechanically activated implants that would preclude MRI
- Allergy to Gadavist IV contrast
- History of cardiac arrhythmias
- Pregnancy or breastfeeding women
- Women of child-bearing age that are sexually active and not using birth control
- Cognitively impaired individuals
- Weight above 260 pounds (lbs)
The study team makes the final eligibility decision.
Where it's taking place
- Houston, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Houston, Texas, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.